ABCL Abcellera Biologics Inc

USD 3.06 -0.31 -9.198812999999999
Icon

Abcellera Biologics Inc (ABCL) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.06

-0.31 (-9.20)%

USD 0.92B

1.34M

USD 7.00(+128.76%)

USD 16.25 (+431.05%)

Icon

ABCL

Abcellera Biologics Inc (USD)
COMMON STOCK | NSD
USD 3.06
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.92B

USD 16.25 (+431.05%)

USD 3.06

Abcellera Biologics Inc (ABCL) Stock Forecast

USD 7.00
(+128.76%)

Based on the Abcellera Biologics Inc stock forecast from 2 analysts, the average analyst target price for Abcellera Biologics Inc is USD 7.00 over the next 12 months. Abcellera Biologics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Abcellera Biologics Inc is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, Abcellera Biologics Inc’s stock price was USD 3.06. Abcellera Biologics Inc’s stock price has changed by -2.24% over the past week, +1.32% over the past month and -59.52% over the last year.

No recent analyst target price found for Abcellera Biologics Inc
No recent average analyst rating found for Abcellera Biologics Inc

Company Overview Abcellera Biologics Inc

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ...Read More

https://www.abcellera.com

2215 Yukon Street, Vancouver, BC, Canada, V5Y 0A1

586

December

USD

USA

Adjusted Closing Price for Abcellera Biologics Inc (ABCL)

Loading...

Unadjusted Closing Price for Abcellera Biologics Inc (ABCL)

Loading...

Share Trading Volume for Abcellera Biologics Inc Shares

Loading...

Compare Performance of Abcellera Biologics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ABCL

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Abcellera Biologics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -0.25 (-0.05%) USD127.00B 31.94 20.00

ETFs Containing ABCL

Symbol Name ABCL's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Abcellera Biologics Inc (ABCL) Stock

Based on ratings from 2 analysts Abcellera Biologics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 3 buy, sell and hold ratings.

Unfortunately we do not have enough data on ABCL's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for ABCL is USD 7.00 over the next 12 months. The maximum analyst target price is USD 9 while the minimum anlayst target price is USD 5.

ABCL stock's Price/Earning ratio is 12.33. Our analysis grades ABCL stock's Price / Earning ratio at F. This means that ABCL stock's Price/Earning ratio is above 60% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ABCL may be a overvalued for its sector.

The last closing price of ABCL's stock was USD 3.06.

The most recent market capitalization for ABCL is USD 0.92B.

Based on targets from 2 analysts, the average taret price for ABCL is projected at USD 7.00 over the next 12 months. This means that ABCL's stock price may go up by +128.76% over the next 12 months.

We can't find any ETFs which contains Abcellera Biologics Inc's stock.

As per our most recent records Abcellera Biologics Inc has 586 Employees.

Abcellera Biologics Inc's registered address is 2215 Yukon Street, Vancouver, BC, Canada, V5Y 0A1. You can get more information about it from Abcellera Biologics Inc's website at https://www.abcellera.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...